150 related articles for article (PubMed ID: 33555271)
21. [Differential diagnosis in adrenal gland tumors using PET and 11C-metomidate].
Juhlin C; Törnblom S; Rastad J; Bergström M; Bonasera T; Sundin A; Långström B
Nord Med; 1998 Nov; 113(9):306-7. PubMed ID: 9835764
[TBL] [Abstract][Full Text] [Related]
22. Something old, something new, PET in adrenal imaging.
Gross MD; Rubello D
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1233-5. PubMed ID: 18338165
[No Abstract] [Full Text] [Related]
23. A simple and efficient automated cGMP-compliant radiosynthesis of [
Kovac M; Miklovicz T; Li L; Russell J; Canales Candela R; Aigbirhio F; Boros I
J Labelled Comp Radiopharm; 2019 Apr; 62(4):190-197. PubMed ID: 30690759
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of primary aldosteronism in chronic kidney disease by I-131 NP-59 SPECT/CT imaging.
Chen YC; Su YC; Chiu JS; Tseng CE
Clin Nucl Med; 2012 Feb; 37(2):e30-2. PubMed ID: 22228361
[TBL] [Abstract][Full Text] [Related]
25. The role of PET in localization of neuroendocrine and adrenocortical tumors.
Eriksson B; Bergström M; Sundin A; Juhlin C; Orlefors H; Oberg K; Långström B
Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551
[TBL] [Abstract][Full Text] [Related]
26. Fast and reliable analysis of veterinary metomidate and etomidate in human blood samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a postmortem case.
Yum H; Jeong S; Jang M; Moon S; Kang M; Kim B; Kim D; Choe S; Yang W; Kim J; Han SB
J Forensic Sci; 2021 Nov; 66(6):2532-2538. PubMed ID: 34405913
[TBL] [Abstract][Full Text] [Related]
27. Subtyping of Patients with Primary Aldosteronism: An Update.
Lenders JWM; Eisenhofer G; Reincke M
Horm Metab Res; 2017 Dec; 49(12):922-928. PubMed ID: 29202492
[TBL] [Abstract][Full Text] [Related]
28. Radiosynthesis of [124I]iodometomidate and biological evaluation using small-animal PET.
Kvaternik H; Wanek T; Hammerschmidt F; Zolle I; Aigner R; Kuntner C
Mol Imaging Biol; 2014 Jun; 16(3):317-21. PubMed ID: 24163019
[TBL] [Abstract][Full Text] [Related]
29.
Ouyang J; Hardy R; Brown M; Helliwell T; Gurnell M; Cuthbertson DJ
J Hum Hypertens; 2017 Jul; 31(7):483-484. PubMed ID: 28276424
[No Abstract] [Full Text] [Related]
30. Imaging of adrenocortical metastases with [11C]metomidate.
Mitterhauser M; Dobrozemsky G; Zettinig G; Wadsak W; Vierhapper H; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):974. PubMed ID: 16721573
[No Abstract] [Full Text] [Related]
31. Use of NP-59 SPECT/CT imaging in atypical primary aldosteronism.
Chen YC; Chiu JS; Tseng CE; Chen YC
QJM; 2014 Mar; 107(3):233-4. PubMed ID: 23674720
[No Abstract] [Full Text] [Related]
32. Myocardial scintigraphic characteristics in patients with primary aldosteronism.
Abe M; Hamada M; Matsuoka H; Shigematsu Y; Sumimoto T; Hiwada K
Hypertension; 1994 Jan; 23(1 Suppl):I164-7. PubMed ID: 8282351
[TBL] [Abstract][Full Text] [Related]
33. A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of Primary Aldosteronism.
Abe T; Naruse M; Young WF; Kobashi N; Doi Y; Izawa A; Akama K; Okumura Y; Ikenaga M; Kimura H; Saji H; Mukai K; Matsumoto H
J Clin Endocrinol Metab; 2016 Mar; 101(3):1008-15. PubMed ID: 26756116
[TBL] [Abstract][Full Text] [Related]
34. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism?
Spyridonidis TJ; Apostolopoulos DJ
Hell J Nucl Med; 2013; 16(2):134-9. PubMed ID: 23865085
[TBL] [Abstract][Full Text] [Related]
35. Utility of F-18 FDG-PET in detecting primary aldosteronism in patients with bilateral adrenal incidentalomas.
Ko MK; Park CS; Byun SS; Hong JM; Lee MY; Kim KH; Na YW; Choi HJ; Nam-Goong IS; Kim YI; Kim ES
J Korean Med Sci; 2013 Mar; 28(3):489-92. PubMed ID: 23486738
[TBL] [Abstract][Full Text] [Related]
36. Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.
Mendichovszky IA; Powlson AS; Manavaki R; Aigbirhio FI; Cheow H; Buscombe JR; Gurnell M; Gilbert FJ
Diagnostics (Basel); 2016 Nov; 6(4):. PubMed ID: 27869719
[TBL] [Abstract][Full Text] [Related]
37. Radiosynthesis of carbon-11-labeled camptothecin derivatives as potential positron emission tomography tracers for imaging of topoisomerase I in cancers.
Gao M; Miller KD; Sledge GW; Zheng QH
Bioorg Med Chem Lett; 2005 Sep; 15(17):3865-9. PubMed ID: 15993064
[TBL] [Abstract][Full Text] [Related]
38. Positron-emission tomography in imaging and staging prostate cancer.
Farsad M; Schiavina R; Franceschelli A; Sanguedolce F; Castellucci P; Bertaccini A; Brunocilla E; Manferrari F; Concetti S; Garofalo M; Rocca C; Borghesi M; Franchi R; Fanti S; Nanni C; Martorana G
Cancer Biomark; 2008; 4(4-5):277-84. PubMed ID: 18957716
[TBL] [Abstract][Full Text] [Related]
39. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma.
Kaji M; Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Ann Thorac Surg; 2007 Jan; 83(1):312-4. PubMed ID: 17184694
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
